Artwork

Content provided by BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies

41:49
 
Share
 

Manage episode 379814879 series 1551347
Content provided by BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Are you interested in exploring cutting-edge autoimmune medicines? In this episode of BioTalk with Rich Bendis, we're delving deep into the world of transformative therapies with two remarkable guests, Dr. Chris Chapman and Dr. Adam Kaplin, from MyMD Pharmaceuticals. MyMD Pharmaceuticals is on a mission to make that a reality. Their lead clinical candidate, MYMD-1®, has the potential to reshape the entire field. But how does MYMD-1 work, and what sets it apart from current treatments? Join us as we unravel the science behind this revolutionary therapy and explore the potential indications and patient populations it could benefit. And that's not all. We also spotlight Supera-CBD, a novel synthetic cannabidiol with incredible potency and anti-inflammatory effects. How could this innovation change the landscape of chronic pain and anxiety management? Don't miss this episode of BioTalk with Rich Bendis as we embark on a journey into the future of autoimmune medicine with MyMD Pharmaceuticals. Tune in now and be part of the conversation.

  continue reading

167 episodes

Artwork
iconShare
 
Manage episode 379814879 series 1551347
Content provided by BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Are you interested in exploring cutting-edge autoimmune medicines? In this episode of BioTalk with Rich Bendis, we're delving deep into the world of transformative therapies with two remarkable guests, Dr. Chris Chapman and Dr. Adam Kaplin, from MyMD Pharmaceuticals. MyMD Pharmaceuticals is on a mission to make that a reality. Their lead clinical candidate, MYMD-1®, has the potential to reshape the entire field. But how does MYMD-1 work, and what sets it apart from current treatments? Join us as we unravel the science behind this revolutionary therapy and explore the potential indications and patient populations it could benefit. And that's not all. We also spotlight Supera-CBD, a novel synthetic cannabidiol with incredible potency and anti-inflammatory effects. How could this innovation change the landscape of chronic pain and anxiety management? Don't miss this episode of BioTalk with Rich Bendis as we embark on a journey into the future of autoimmune medicine with MyMD Pharmaceuticals. Tune in now and be part of the conversation.

  continue reading

167 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide